Broadcast Date: December 17, 2020
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

The numbers and complexities of molecules that are screened and quantified in a clinical research laboratory continue to grow at a significant rate. Molecule types span between small and large, thus adding to the challenges typically faced in developing robust, reliable, and reproducible analytical methods.

Liquid chromatography, coupled to mass spectrometry, has been a popular technology owing to its specificity and selectivity while achieving sensitivity and reproducibility requirements. This GEN webinar will focus on demonstrating the capabilities of the new generation Thermo Scientific™ Orbitrap™ Exploris™ mass spectrometry platforms and how they can be capitalized to address challenging analytical experiments in the domain of protein quantitation. Moreover, our presenters will discuss the role of mass spectrometry in protein quantification with relation to anti-doping, infectious disease, and potential disease biomarker discovery.

A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.

Debadeep Bhattacharyya, PhD
Debadeep Bhattacharyya, PhD
Sr. Manager, Marketing,
Clinical and Forensic
Yu Zhou, PhD
Yu Zhou, PhD
Senior Application Scientist
Thermo Fisher Scientific

Thermo Fisher logo

The post Confidence in Clinical Protein Quantitation Begins with a New Generation of LC-MS appeared first on GEN – Genetic Engineering and Biotechnology News.